Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer

This study has been completed.
National Cancer Institute (NCI)
Information provided by:
Case Comprehensive Cancer Center Identifier:
First received: July 5, 2000
Last updated: June 9, 2010
Last verified: June 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2005
  Primary Completion Date: July 2003 (Final data collection date for primary outcome measure)